American Journal of Therapeutics · 2001 · 61 citations · 9 references
MedicinePediatricsPharmacotherapyClinical PharmacologyGastroenterologyPediatric PharmacotherapyHypoglycemia ManagementPediatric Gastrointestinal DisordersPediatric PharmacologyBolus Intravenous DosingIntermittent Bolus AdministrationIntermittent Dosing RegimensIntermittent Intravenous Infusion
Octreotide is a somatostatin analogue that has been suggested as a therapeutic agent in various diverse disease processes including gastrointestinal bleeding, pancreatitis, hypoglycemia related to hyperinsulin states, and chylous peritoneum/thorax. Despite successful use in the adult population, there is limited information concerning its use in pediatric patients. The authors retrospectively review their experience with octreotide in 10 infants and children ranging in age from 14 days to 17 years. Octreotide, administered by continuous intravenous infusion or intermittent bolus dosing, was used in the treatment of gastrointestinal bleeding in four patients, pancreatitis in three patients, chylous leaks in two patients, and hypoglycemia related to nesidioblastosis in one patient. The clinical course of these patients and the potential therapeutic impact of octreotide are evaluated. Additionally, previous experiences with octreotide in pediatric patients, dosing regimens, and the potential role of the drug in other disease processes are discussed.
9
Sclerotherapy with or without Octreotide for Acute Variceal Bleeding
Isabelle Besson, Pierre Ingrand, Bruno Person et al. · New England Journal of Medicine · 1995 · 276 citations · Full text
The use of somatostatin and its analogs in the treatment of surgical disorders.
Sean J. Mulvihill, Theodore N. Pappas, Edward Passaro et al. · PubMed · 1986 · 73 citations
Medicine, Endocrinology, Surgery +6
Surfactant Replacement Therapy
G. McClure · Archives of Disease in Childhood · 1990 · 72 citations · Full text